Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal Jeffries

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Blood|May 16, 2022
A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell diseaseJulia Z Xu, Anna Conrey, Ingrid Frey, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 17, 2019
INTERMACS profiles and outcomes of ambulatory advanced heart failure patients: A report from the REVIVAL RegistryMichelle M Kittleson, Palak Shah, Anuradha Lala, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 11, 2021
An early relook identifies high-risk trajectories in ambulatory advanced heart failureMichelle M Kittleson, Amrut V Ambardekar, Lynne W Stevenson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 13, 2016
The NHLBI REVIVE-IT study: Understanding its discontinuation in the context of current left ventricular assist device therapyFrancis D Pagani, Keith D Aaronson, Robert Kormos, et al.
Journal of the American Heart Association|July 12, 2021
Caregiver Health-Related Quality of Life, Burden, and Patient Outcomes in Ambulatory Advanced Heart Failure: A Report From REVIVALNisha A Gilotra, Salpy V Pamboukian, Maria Mountis, et al.
Journal of the American College of Cardiology|April 24, 2024
Permanent Pacemaker Implantation and Long-Term Outcomes of Patients Undergoing Concomitant Mitral and Tricuspid Valve SurgeryAlexander Iribarne, Sundos H Alabbadi, Alan J Moskowitz, et al.
The New England Journal of Medicine|November 19, 2014
Surgical treatment of moderate ischemic mitral regurgitationPeter K Smith, John D Puskas, Deborah D Ascheim, et al.
JAMA|March 16, 2019
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical TrialDouglas L Packer, Daniel B Mark, Richard A Robb, et al.
JAMA|March 27, 2019
Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical TrialTerrence M Yau, Francis D Pagani, Donna M Mancini, et al.
The New England Journal of Medicine|April 5, 2016
Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral RegurgitationRobert E Michler, Peter K Smith, Michael K Parides, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Blood|May 16, 2022
A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell diseaseJulia Z Xu, Anna Conrey, Ingrid Frey, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 17, 2019
INTERMACS profiles and outcomes of ambulatory advanced heart failure patients: A report from the REVIVAL RegistryMichelle M Kittleson, Palak Shah, Anuradha Lala, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 11, 2021
An early relook identifies high-risk trajectories in ambulatory advanced heart failureMichelle M Kittleson, Amrut V Ambardekar, Lynne W Stevenson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 13, 2016
The NHLBI REVIVE-IT study: Understanding its discontinuation in the context of current left ventricular assist device therapyFrancis D Pagani, Keith D Aaronson, Robert Kormos, et al.
Journal of the American Heart Association|July 12, 2021
Caregiver Health-Related Quality of Life, Burden, and Patient Outcomes in Ambulatory Advanced Heart Failure: A Report From REVIVALNisha A Gilotra, Salpy V Pamboukian, Maria Mountis, et al.
Journal of the American College of Cardiology|April 24, 2024
Permanent Pacemaker Implantation and Long-Term Outcomes of Patients Undergoing Concomitant Mitral and Tricuspid Valve SurgeryAlexander Iribarne, Sundos H Alabbadi, Alan J Moskowitz, et al.
The New England Journal of Medicine|November 19, 2014
Surgical treatment of moderate ischemic mitral regurgitationPeter K Smith, John D Puskas, Deborah D Ascheim, et al.
JAMA|March 16, 2019
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical TrialDouglas L Packer, Daniel B Mark, Richard A Robb, et al.
JAMA|March 27, 2019
Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical TrialTerrence M Yau, Francis D Pagani, Donna M Mancini, et al.
The New England Journal of Medicine|April 5, 2016
Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral RegurgitationRobert E Michler, Peter K Smith, Michael K Parides, et al.
Pageof 6